Sodium-glucose cotransporter 2 (SGLT-2): Cause of prolonged euglycaemic ketoacidosis and ketonaemia following general anaesthesia?

被引：0
|
作者：
Chong, Z. M. [1 ]
Stirling, A. [1 ]
Sandeep, T. [1 ]
机构：
[1] Monklands Hosp, Diabet & Endocrinol, Airdrie, Lanark, Scotland
来源：
DIABETIC MEDICINE | 2018年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P205
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [31] Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors
    Grempler, R.
    Thomas, L.
    Eckhardt, M.
    Himmelsbach, F.
    Sauer, A.
    Sharp, D. E.
    Bakker, R. A.
    Mark, M.
    Klein, T.
    Eickelmann, P.
    DIABETES OBESITY & METABOLISM, 2012, 14 (01): : 83 - 90
  • [32] Underutilization of Sodium-Glucose Cotransporter 2 ( SGLT-2) Inhibitors in Diabetic Nephropathy Patients in Government-Run Hospitals in India
    Maradia, Jay
    Joshi, Shirish S.
    Sohal, Amitoj
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [33] Stroke safety with Sodium-Glucose Cotransporter-2 (SGLT-2) inhibitor use: a systematic review and meta-analysis
    Roddick, A. J.
    Zheng, S. L.
    DIABETOLOGIA, 2018, 61 : S308 - S308
  • [34] Anti-Inflammatory Effect for Atherosclerosis Progression by Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitor in a Normoglycemic Rabbit Model
    Lee, Seul-Gee
    Lee, Seung-Jun
    Lee, Jung-Jae
    Kim, Jung-Sun
    Lee, Oh-Hyun
    Kim, Choong-Ki
    Kim, Darae
    Lee, Yong-Ho
    Oh, Jaewon
    Park, Seit
    Jeon, Ok-Hee
    Hong, Sung-Jin
    Ahn, Chul-Min
    Kim, Byeong-Keuk
    Ko, Young-Guk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yansoo
    KOREAN CIRCULATION JOURNAL, 2020, 50 (05) : 443 - 457
  • [35] Sodium-Glucose Cotransporter-2 (SGLT-2) Attenuates Serum Uric Acid (SUA) Level in Patients with Type 2 Diabetes
    Hussain, Mazhar
    Elahi, Asim
    Hussain, Abid
    Iqbal, Javed
    Akhtar, Lubna
    Majid, Abdul
    JOURNAL OF DIABETES RESEARCH, 2021, 2021
  • [36] ASSOCIATION BETWEEN SODIUM-GLUCOSE COTRANSPORTER-2 (SGLT-2) INHIBITORS AND LOWER EXTREMITY AMPUTATION: A RETROSPECTIVE COHORT STUDY
    Chang, I. I.
    Singh, S.
    Mansour, O.
    Baksh, S.
    Alexander, G. C.
    VALUE IN HEALTH, 2018, 21 : S71 - S72
  • [37] Association between sodium-glucose cotransporter-2 (SGLT-2) inhibitors and lower extremity amputation: A retrospective cohort study
    Chang, Hsien-Yen
    Singh, Sonal
    Mansour, Omar
    Baksh, Sheriza
    Alexander, G. Caleb
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 485 - 485
  • [38] EUGLYCEMIC DIABETIC KETOACIDOSIS WITH ELEVATED ACETONE IN A PATIENT TAKING A SODIUM-GLUCOSE COTRANSPORTER-2 (SGLT2) INHIBITOR
    Andrews, Tory J.
    Cox, Robert D.
    Parker, Christina
    Kolb, James
    JOURNAL OF EMERGENCY MEDICINE, 2017, 52 (02): : 223 - 226
  • [39] Prolonged Glucosuria With Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Case Report and Review of Literature
    Aggarwal, Ankita
    Jain, Anubhav
    Sachdeva, Sonali
    Kulairi, Zain, I
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (11)
  • [40] Euglycaemic diabetic ketoacidosis as a complication of SGLT-2 inhibitors: epidemiology, pathophysiology, and treatment
    Sampani, Erasmia
    Sarafidis, Pantelis
    Papagianni, Aikaterini
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (06) : 673 - 682
12345